ImYoo
PrivateLast Round
Accelerator
Dec 2, 2024
Total Funding Raised
$100,000
Momentum
Top 5%
of companies Caplight tracks
Company Overview
ImYoo is a biotechnology company that provides a patient-enabled biodiscovery platform for at-home blood sample collection and single-cell multi-omic analysis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Usage-Based SaaS, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ImYoo Comparables
Compare ImYoo with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Scailyte AG | 76% | |
| Neomend | 72% | |
| Sano Genetics | 68% |
ImYoo Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Dec 2, 2024 | ||||
| Seed | Jul 31, 2022 |
Key People
Founding team and executive leadership
ImYoo Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Merck Global Health Innovation Fund | Accelerator |
| Arben Ventures | Seed |
| Freeflow Ventures | Seed |
| Corundum Systems Biology | Seed |
| New Jersey Innovation Institute | Accelerator |
| Boost VC | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 883% MoM, from 144 to 1.4K.
- May 15, 2026
Monthly visitors grew 548% MoM, reaching 1.1K.
ImYoo Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ImYoo's valuation, stock price, and market status.
Is ImYoo a public or private company?
ImYoo is a private company.
What is the current stock price of ImYoo?
ImYoo is a private company with no public stock price. No recent secondary market data is available.
How much is ImYoo worth (valuation)?
Valuation information for ImYoo is not publicly available.
Can I buy ImYoo stock?
ImYoo shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ImYoo's last funding round?
ImYoo's most recent funding round was Accelerator on December 2, 2024.
Who are the main investors in ImYoo?
Key investors in ImYoo include Corundum Systems Biology.
Will ImYoo IPO soon?
No public IPO plans have been announced for ImYoo.
How can I track ImYoo secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ImYoo's secondary market activity and sign up for updates.